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Immune regulation of the skin plays an important role 
in susceptibility and development of illnesses. The aim of 
our study was to localise the interleukin (IL)-10 family 
of cytokines, in children’s skin and to determine pos-
sible age-related differences in the expression level. The 
mRNA expression level of IL10, IL19, IL20, IL22, IL24, 
IL26, IL28B, IL29 and their receptors IL10RA, IL10RB, 
IL20RA, IL20RB, IL22RA1, IL22RA2, IL28RA was 
compared in skin biopsies of children and adults and in 
childrens’ skin cells by quantitative real-time PCR (qRT-
PCR). Immunohistochemistry was performed to confirm 
the qRT-PCR findings. We found age-related differences 
in the expression of IL10RB, IL20, IL20RA, IL22RA1, 
IL22RA2, IL26 and IL28RA genes. Cell type-dependent 
expression of IL10 family cytokines was apparent in the 
skin. In addition to previously known differences in sys-
temic immunological response of adults and children, 
the present results reveal differences in immune profile 
of adult and juvenile skin. Key words: IL10 family cyto-
kines; gene expression; skin; children’s immune system.
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It is well known that during the first years of life, several 
changes occur leading to the formation of individual im-
mune state. Transient fluctuations in the immunoglobulin 
levels are common until the end of the second year of 
life, but may be present even up to the 6th year of life 
(1, 2). The production level of cytokines such as inter-
leukin (IL)1α, IL1β, and TNFα is lower, fluctuating or 
inadequate compared to adults (3), which explains the 
variability in the severity of infections in children and also 
the vulnerability to sepsis as a result of an overreaction 
of the immune system.
Comparative studies of the immune system of adults 
and children have usually been based on the analysis 
of blood. However, skin is the most effective barrier 
between the organism and the environment. During the 
first year of life, skin is in a state of active development. 
Compared to adults there are differences in microstruc-
ture density, cell size, epidermal layer thickness, dermal 
structure, and the density of papillae in the infant’s skin 
(4). The features of immune mechanisms in the skin 
of children have so far been poorly studied and a few 
comparative gene expression studies have been made 
between the skin of adults and children (5, 6).
The IL10 family includes a number of cellular cytoki-
nes: IL10, IL19, IL20, IL22, IL24, IL26, IL28A, IL28B, 
and IL29. This classification is based on distinctive six-
alpha-helix structure that is common to all mature IL10 
family members. They also share up to 28% of their 
amino acid structure (7, 8). However, receptor-binding 
units of IL10 family cytokines are variable, defining 
interaction with different receptors (9, 10) (Table SI1). 
The variability of binding sites may cause differences 
in the biological action of these ILs. 
All receptors of IL10 family cytokines (IL10RA, 
IL10RB, IL20RA, IL20RB, IL22RA1, IL22RA2 and 
IL28RA) belong to class II cytokine receptor family (11, 
12) commonly composed of ligand-binding alpha subunit 
and signal-transducing beta or gamma chain subunits. 
The IL10 family of cytokines are responsible for 
host defense mechanisms, they can improve the heal-
ing process in injuries, limit infection-caused damages 
or modify inflammation by promoting innate immune 
responses in epithelial tissue. A number of IL10 family 
cytokines have both pro-inflammatory and anti-inflam-
matory roles (13, 14) making the investigation of their 
individual functions quite complicated.
Recent results suggest that the IL10 family of cyto-
kines are involved in the function of skin as well as in 
the pathogenesis of major skin diseases (e.g. psoriasis) 
(15, 16). Our group has described the expression profile 
differences of the IL10 family of cytokines in whole 
skin and blood samples of vitiligo patients, compared 
to healthy controls (17). In order to describe differences 
in the mRNA expression of IL10 family interleukins 
in the skin of adults and children we compared gene 
expression levels in whole skin samples of healthy sub-
jects. To confirm our results, we also analysed samples 
for the expression of respective proteins in adults’ and 
children’s whole skin. In addition, gene expression was 
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analysed in each of the 3 main cell types (keratinocy-
tes, melanocytes and fibroblasts) of the skin of healthy 
infants. Taken together, the aim of our study was to 
analyse the IL10 family cytokine expression in the skin 
and to determine possible age-related differences in the 
expression level. 
mATERIALS AND mETHoDS
 A written informed consent was obtained from all patients. All 
procedures were carried out in accordance with the ethical stan-
dards of the Research Ethics Committee of the University of Tartu.
Subjects
We had 5 different sets of samples to measure gene expres-
sion: adults’ whole skin, children’s whole skin, and children’s 
keratinocytes, fibroblasts and melanocytes.
We isolated keratinocytes, melanocytes and fibroblasts from 
15 paediatric foreskins of healthy circumcised patients (aged 
5 months to 10 years) and measured gene expression from the 
established cell cultures. The same paediatric samples were used 
to measure gene expression in children’s whole skin. The children 
were recruited from elective patients present at the Department of 
Pediatric Surgery, Tallinn Children’s Hospital, with no concurrent 
diseases and signs of infection. Skin tissue was divided into two 
parts. A tissue sized 4 mm was transferred into RNALater (Life 
Technologies Co, USA) for RNA extraction and the remaining 
tissue part into 0.9% NaCl solution for cell culture. Existing 
protocols of isolating and growing skin cells were used (18).
Punch-biopsies of 4 mm were taken from 15 healthy adult 
volunteers (aged 19 to 79 years) without known skin diseases 
from non sun-exposed areas. Healthy adult volunteers were 
recruited from patients attending the outpatient clinic of the 
Department of Dermatology of the University of Tartu. Biop-
sies were instantly snap-frozen in liquid nitrogen and stored at 
–80°C until used for RNA extraction.
Cell culture
Skin pieces from juvenile skin were rinsed in phosphate-buffered 
saline (PBS w/o Ca, mg, PAALaboratories gmbH, Pasching, 
Austria). Subcutaneous fat was removed and tissue was incubated 
in dispase II diluted in PBS (2.4 U/ml, Sigma-Aldrich, munich, 
germany) at +4ºC overnight. Epidermis was peeled off from 
the dermis, transferred into 0.05% trypsin/0.02% EDTA (Life 
Technologies Co, USA) for 3 min at 37°C. Enzymatic process 
was stopped with trypsin inhibitor (Sigma-Aldrich). We used 
cell-specific selective media to isolate a particular cell type cul-
ture: EpiLife® basal medium with human keratinocyte growth 
supplement (Life Technologies Co, USA) and melanocyte growth 
medium m2 with supplement mix (PromoCell, Heidelberg, ger-
many). melanocyte culture dishes were precoated with gelatin. 
A piece of dermis was used for isolation of fibroblasts by 
migration method. The dermis was rinsed in PBS, cut into 4 × 4 
mm pieces and attached onto a culture dish, covered with 10 
ml of DmEm (PAA Laboratories gmbH, Austria) with 10% 
foetal bovine serum (Sigma-Aldrich), penicillin (100 UI/ml), 
streptomycin (100 μg/ml) (PAA Laboratories GmbH, Cölbe, 
germany) and amphotericine B 250 ng/ml. The medium was 
changed every 2nd day throughout the study.
Subculture (passage) of cells was done with 65–90% cellu-
lar confluence in the Petri dish maximum 3 times. Cells with 
passage No. 2–3, were used for subsequent isolation of RNA.
Lipopolysaccharide stimulation
Reaching approximately 90% confluence, melanocytes and 
fibroblasts were incubated with media alone (controls) and 
lipopolysaccharide (LPS) (E. coli 0111:B4, Sigma-Aldrich) 
with 10 ng/ml for 12 h. After treatment, the cells were washed 
with PBS and used for isolation of RNA for qRT-PCR.
RNA extraction
The skin biopsies were homogenised using T10 basic homo-
geniser (IKA Labortechnik, Staufen, germany) and total RNA 
was isolated from tissues with RNeasy Fibrous Tissue Mini 
Kit (Qiagen, Valencia CA, USA). The RNA from cells was 
extracted using Trizol® reagent (Life Technologies Co, USA) 
RNeasy mini columns (Qiagen) combined protocol. The RNA 
content was determined by spectrophotometry and 500 ng of 
each sample was used to synthesise cDNA using High Capacity 
cDNA Reverse Transcription Kit (Life Technologies Co) ac-
cording to the manufacturer’s protocol.
Quantitative real-time PCR
RNA expression was observed using qRT-PCR (7900 Fast QRT-
PCR, Life Technologies Co). Two primers and labelled probe 
were used to detect the mRNA expression level of the reference 
gene hypoxanthine phosphoribosyl-transferase-1 (HPRT-1) 
(primer sequences avilable upon request). Expression levels of 
other genes under investigation were detected using following 
20x probe assays (Life Technologies Co): IL10 (Hs00174086_
m1), IL10RA (Hs00155485_m1), IL10RB (Hs00175123_
m1), IL19 (Hs00203540 m1), IL20 (Hs00218888_m1), 
IL20RA (Hs00205346_m1), IL20RB (Hs00376373_m1), 
IL22RA1 (Hs00222035_m1), IL22RA2 (Hs00364814_m1), 
IL24 (Hs00169533_m1), IL26 (Hs00218189_m1), IL29 
(Hs00601677_g1), IL28RA (Hs00417120_m1).
Statistical analysis
The relative gene expression levels were calculated using 2-∆CT 
method utilising the housekeeping gene HPRT-1 as an internal 
control (19).
The data of all studied genes that followed normal distribu-
tion (using D’Agostino & Pearson omnibus normality test) 
were parametrically tested by unpaired t-test and the data not 
following the normal distribution by mann-Whitney t-test. 
Immunohistochemistry
Skin pieces from adults and children (n = 5 in both group) for im-
munohistochemistry (IHC) were fixed immediately after exci-
sion in 10% formaline for 24 h and paraffinised. Deparaffinised 
sections were treated with 3% H2o2 followed by Dako REAL 
Antibody Diluent (Dako Denmark A/S, glostrup, Denmark) to 
block non-specific binding. After blocking, sections were incu-
bated with rabbit polyclonal antibody to IL29 (ab38569) 1:100, 
IL28 receptor alpha (ab83865) 1:200, IL22 RA2 (ab96341) 
1:500, IL26 (ab102977) 1:200 or IL10RB (ab106282) 1:200 
overnight at 4°C (all antibodies were purchased from Abcam 
Ltd., Cambridge, UK). Visualisation of the primary antibodies 
was performed by using Dako REAL™ EnVision™ Detection 
System (Dako Denmark A/S). The washing steps were carried 
out with PBS containing 0.07% of Tween 20. Thionine blue 
(Sigma-Aldrich) was used for background staining. No immu-
nohistochemical staining was noted in negative controls where 
the primary antibody was omitted. 
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RESULTS
We discovered that IL10 is expressed similarly in 
children’s and adults’ skin (Fig. 1a), but the expression 
in the juvenile skin cell cultures was undetectable (data 
not shown). IL10RA was equally detectable in children’s 
as well as in adults’ skin (Fig. 1b). In cell cultures 
IL10RA expression was similar in the melanocytes and 
fibroblasts of adults and children while in keratinocytes 
the expression level was below the detection limit (Fig. 
2a). IL10RB expression analysis revealed a statistical 
difference between children’s and adults’ skin, the latter 
being much higher (Fig. 1c). This was also confirmed by 
IHC, which revealed clearly higher immunoreactivity in 
adults’ skin (Fig. 3 a, g). High IL10RB immunoreactivity 
was found in all layers of adults’ skin. These findings 
were corroborated by mRNA expression studies in juve-
nile cell culture demonstrating similar expression level 
of IL10RB in all studied cell types (Fig. 2b). 
In children, IL20 expression was highly variable, 
whereas in adults’ skin it was undetectable (Fig. 1d). In 
cell cultures, IL20 expression could be observed only 
in keratinocytes (Fig. 2c). 
IL20RA was expressed higher in adults’ skin com-
pared with children’s whole skin (p = 0.0015, mann 
Whitney test) (Fig. 1e). The expression level of IL20RA 
was significantly higher in juvenile keratinocytes than in 
fibroblasts and absent in melanocytes (Fig. 2d). IL20RB 
expression level was similarly high in children’s and 
adults’ skin (Fig. 1f). In cell culture from children, 
IL20RB expression was the highest in keratinocytes 
compared to being barely detectable in melanocytes 
and fibroblasts (Fig. 2e). 
Both IL22RA1 and IL22RA2 expression levels were 
significantly higher in children’s skin (p < 0.0001, un-
paired t-test) (Fig. 1g, h). In cell culture, the expression 
level of IL22RA1 was similar in keratinocytes and 
fibroblasts, whereas no expression could be detected in 
melanocytes (Fig. 2f). No expression of IL22RA2 (as 
well as IL10) could be detected in these 3 cell cultures 
(data not shown). No IL22RA2 antibody staining was 
detected by IHC (Fig. 3b, h). 
IL24 RNA was not detectable in children’s and adults’ 
whole skin (data not shown), however, it became de-
tectable after seeding the cells into cell cultures. The 
expression level of IL24 was the highest in melanocytes 
compared to keratinocytes and the weakest in fibroblasts 
(Fig. 2g). Notably, IL24 was the only studied gene in-
duced by LPS stimulation in cell culture, increasing up 
to 10 times in melanocytes (Fig. 2g).
The expression of IL26 was low and relatively variable 
in children’s skin, whereas in adults, no IL26 gene expres-
sion could be detected (Fig. 1i), nor was IL26 detected in 
children’s skin cells (data not shown). IHC revealed no 
observable IL26 antibody staining (Fig. 3c, i).
Fig. 1. mRNA expression of studied genes in adults’ and children’s whole skin. 
Data is plotted as the mean of 15 replicates ± SD. p-values are shown on graphs. 
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The expression of IL28RA gene was much higher in 
children’s skin than in adults’ skin (Fig. 1j). IL28RA 
protein staining was not significant in children’s skin 
(Fig. 3d). In adults’ skin IHC analysis revealed a 
IL28RA positive staining in epidermis (Fig. 3j). In the 
juvenile cell culture, IL28RA gene expression was the 
highest in keratinocytes but no expression was detec-
table in fibroblasts (Fig. 2h). 
An overview of the expression levels of IL10 fa-
mily genes in adults’ and children’s whole skin and in 
children’s skin cells is presented in Table I. Expression 
of IL19, IL22, IL28B and IL29 could not be detected in 
neither whole skin nor in cell culture.
DISCUSSIoN
We found that the majority of the genes of IL10 fa-
mily and their receptors were detectable in children’s 
skin (IL10, IL10RA, IL10RB, IL20, 
IL20RA, IL20RB, IL22RA1, IL22RA2, 
IL26, IL28RA). on the other hand, 50% 
of the genes expressed in children’s 
skin were downregulated (IL22RA1, 
IL22RA2, IL28RA) or absent (IL20, IL26) 
in adults (Table I). The results refer to 
the immaturity of the children’s immune 
system. Differences in innate immunity 
function, an amount of antibody produc-
tion (20) and qualitative differences in 
blood cytokine profile (21–24) during 
early life versus adulthood have been 
described previously. our present study 
demonstrates an age-dependent effect on 
cytokines also in skin tissue, based on 
RNA quantification and protein (IHC) 
staining levels. gene expression data 
were verified by whole transcriptome 
sequencing analysis, SoLiDTm (Reemann 
et al., unpublished data). In some cases 
RNA and protein expressions did not 
correlate. The reason for this discrepancy 
is not known, but different regulatory 
mechanisms for RNA and protein expres-
sion may play a potential role. For several 
genes, for example IL10RB, we observed 
a significantly weaker or missing antibody 
reaction in children’s samples compared 
to adults’ (Fig 3a). Together with IL10RA, 
IL10RB has been shown to be required 
for IL10-induced signal transduction and 
therefore may regulate susceptibility to 
different kinds of illnesses. For example 
mutations in IL10R genes cause severe 
and early childhood onset of the inflam-
matory bowel disease (25).
We found that interleukin receptors 
are more prominently expressed in the 
skin than interleukins (Fig. 1). This indicates that skin 
cells are targets for circulating cytokines. There were 
also differences in expression of receptor subunits. 
Interestingly, the expression level of receptor genes 
correlated with the overall prevalence and selectivity 
of respective subunits. For example IL10RA is unique 
to IL10R whereas IL10RB is shared by several other 
cytokines, including IL22, IL26, and IL28A IL28RB 
and IL29 (Table SI1). 
Concurrently, there was a group of genes of the 
IL10 family (IL19, IL22, IL28B, IL29), which have 
been shown to play a role in different skin disorders, 
such  as psoriasis and infections (26–28), but in healthy 
adults’ and children’s skin and cells their expression 
was below the detection limit (Table I). It indicates 
that these cytokines are significantly expressed only in 


















































































   



















   



















   



















   



















   



















   



















   



















   






Fig. 2. mRNA expression of studied genes in children’s skin cells. melanocytes (mc), 
keratinocytes (Kc), fibroblasts (Fb), LPS stimulated melanocytes (Mc_LPS). Data is plotted 
as the mean ± SD of 15 replicates. p-values are shown on graphs. Statistical methods used: 
d, g, h: mann-Whitney t-test, f: Unpaired t-test.
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the new interferon-like cytokines in the IL10 family, 
have been shown to exert their anti-viral, anti-pro-
liferative, anti-tumour activity via the IL28RA and 
IL10RB receptor complex (9, 29). IL28 and IL29 
can act synergistically with IL20 (28), which is one 
of the most investigated potential target cytokines 
for psoriasis treatment (30). Correlating with pre-
vious studies (31), we found IL20 to be absent in 
healthy adults’ skin (Fig. 1d). The reason why IL20 
expression was quite fluctuating but still measurable 
in children’s whole skin and keratinocytes (Fig. 
2c), might be connected to higher cell proliferation 
capacity of cell culture as well as juvenile skin.
In order to localise gene expression of studied 
cytokines we analysed 3 cell types in children’s skin, 
forming the majority of cellular component in the 
epidermis and dermis (melanocytes, keratinocytes 
and fibroblasts). We found that genes, which were 
not detectable in whole skin of both children and 
adults (IL19, IL22, IL28B and IL29) (Fig. 1), were 
also not detectable in cell cultures (Fig. 2). IL24 can 
be pointed out as an exception. IL24, which was 
highly expressed in melanocytes, was not detectable 
in the children’s and adults’ whole skin. Compared 
to fibroblasts and keratinocytes, the number of mela-
nocytes is very small in a skin biopsy and therefore 
in monoculture their characteristics are more easily 
observed. IL24 has been shown to induce growth 
arrest and apoptosis in melanoma cells (32), but is 
also considered an important mediator for chronic 
inflammatory conditions, e.g. psoriasis (33).
From a methodologic point of view we have to 
take into account that despite using low-passage cell 
culture, gene expression could still be influenced 
by in vitro culture conditions (34, 35). This could 
be an issue in the case of IL10, IL22RA2 and IL26 
Fig. 3. Immunohistochemistry (IHC) staining of children’s and adult’s whole skin 
sample. Skin specimens (n = 5, both in children’s (a–f) and adult’s (g–l) group) 
were stained with (blue background staining) and the antibodies for IL10RB, 
IL22RA2, IL26, IL28RA, IL29 (brown colour indicates positive antibody 
reaction); IL10RB (a, g) antibody staining was present in all layers of adults’ 
and juvenile skin, but a significantly weaker antibody reaction in children’s 
samples were observable. We detected IL28RA positive antibody reaction (d, j) 
in adults’ epidermis, but no significant staining in children’s skin. IHC revealed 
no observable antibody staining of IL22RA2, IL26 and IL29. Negative control 
for antibody staining shown in (f, l). Scale bars 200 mm.
Table I. Overview of the expression levels of interleukin (IL)-
10 family genes in adults’ and children’s whole skin, as well 
as in children’s skin cells
genes Children Adults Kc mc Fb
IL10 ++ ++ – – –
IL10RA +++ +++ – + +
IL10RB +++ ++++ +++ +++ +++
IL19 – – – – –
IL20 ++ – ++ – –
IL20RA +++ +++ +++ – ++
IL20RB ++++ ++++ ++++ + ++
IL22 – – – – –
IL22RA1 ++++ +++ +++ – ++
IL22RA2 +++ ++ – – –
IL24 – – ++ +++ +
IL26 ++ – – – –
IL28RA +++ ++ ++ ++ –
IL28B – – – – –
IL29 – – – – –
Kc: keratinocytes; Mc: melanocytes; Fb: fibroblasts; –: undetectable 
expression; +: mean 2-∆CT 0.001–0.009; ++: mean 2-∆CT 0.01–
0.09; +++: mean 2-∆CT ≥ 0.1–0.9; ++++: mean 2-∆CT ≥ 1.
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where gene expression was observed in whole skin, 
but absent in cell culture. Also, mRNA synthesis could 
occur somewhere else than in keratinocytes, melano-
cytes and fibroblasts. For instance, IL26 and a soluble 
receptor IL22RA2, which is considered to be stored in 
the extracellular matrix for on demand releasing (36) 
are produced mainly by resident T cells (37, 38). Al-
though both subunits of IL-22R complex and IL10RB 
are required to form the functional receptor (Table SI1), 
IL22RA2 is able to bind alone to IL22 (39). Unlike 
IL22RA2, which is strictly an antagonist for IL22 ac-
tivity, IL22RA1 regulates both IL22 and IL20 activity 
(Table SI1) and its expression was detectable especially 
in keratinocytes (Fig. 2f). 
To see whether we could upregulate IL10 family cy-
tokines genes and cause an inflammation-like state also 
in vitro, we performed LPS stimulation. LPS, a major 
component of the outer membrane of gram-negative 
bacteria (40) and a strong inflammatory agent, promotes 
the secretion of proinflammatory cytokines such as 
IL1β, tumour necrosis factor α (41) and proinflammatory 
cytokines limiting IL10 (42) from cells. An interesting 
exception came out in our study, as IL24 was the only 
studied gene the expression level which changed sta-
tistically significantly in response to stimulation with 
LPS and that occurred only in children’s melanocyte 
culture (Fig. 2 g). This finding suggests that melanocytes 
can react to the inflammatory signals and are able to 
produce cytokines, which in turn suggests they play a 
role in immune defense mechanisms. The reason why 
other studied interleukins did not respond to stimulation 
could be explained by the previous finding that neonatal 
cells tend to have notably lower cytokine production in 
response to LPS compared to adults (21, 43). 
We believe that a major value of this study lies in 
finding that gene expression differs in adults’ and 
children’s skin and the reason for this could be the im-
maturity of the organism’s defense mechanisms as a 
result of which the reaction to harmful influences, such 
as inflammation and infection, differs. This could also 
explain why several childhood skin diseases go into 
remission, disappear or acquire a different appearance 
in adult age (e.g. atopic dermatitis, juvenile dermato-
myositis and cutaneous mastocytosis). 
From a clinical point of view the comprehension of 
the physiological state of the IL10 family of cytokines 
would be helpful in developing routine laboratory 
techniques for both diagnostics as well as for evaluating 
the effectiveness of treatments. It is also important for 
establishing normal ranges of tests for each age group. 
Analysing skin cells in vitro, we found cell-specific 
cytokine production, which helps to explain the roles 
of different cells in inflammatory system. Juvenile skin 
cells, due to their excellent proliferative capacity, are 
mostly used for tissue-engineered products. Thus, from 
a future research perspective it is crucial to understand 
cell behaviour in an artificial environment, especially 
pro- and antiinflammatory markers, which play a role 
in tissue rejection process. 
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